People · Operator
Named in public records as an officer, director or promoter · active 2016–2018 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BioMarker Strategies LLC | — | Biotechnology | Seed | $7.9M | $23.3M | 2016 |
| HyperMed Imaging, Inc. | — | Other | Series A | $5.0M | $76.3M | 2018 |
Katarzyna Kusmierz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Katarzyna Kusmierz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Glenn Miller | 1 | 5 |
| David Wetherell | 1 | 3 |
| Jason Rubin | 1 | 3 |
| Jack Davis | 1 | 3 |
| Douglas Lind | 1 | 2 |
| Douglas Clark | 1 | 2 |
| Mark Velleca | 1 | 2 |
| Joseph Klein | 1 | 2 |
| Christina Marie Wyskiel | 1 | 1 |
| Jerry Parrott | 1 | 1 |
| Karen Marie Olson | 1 | 1 |
| Cy Cabradilla | 1 | 1 |
| Jay Fik | 1 | 1 |
| Mark Darty | 1 | 1 |
| Christine Wyskiel | 1 | 1 |
| Paul Beresford | 1 | 1 |
| Christina Wyskiel | 1 | 1 |
| Sam Broder | 1 | 1 |
| Scott Allocco | 1 | 1 |
| Karen Olson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.